Nicholas M. Westfall - 02 Nov 2021 Form 4 Insider Report for CHEMED CORP (CHE)

Role
Executive Vice President
Signature
Nicholas M. Westfall
Issuer symbol
CHE
Transactions as of
02 Nov 2021
Transactions value $
-$2,721,395
Form type
4
Filing time
05 Nov 2021, 11:15:57 UTC
Previous filing
02 Nov 2021
Next filing
23 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHE capital stock Sale -$695K -1.42K -18.96% $490.15 6.06K 02 Nov 2021 Direct F1
transaction CHE capital stock Sale -$2.03M -4.18K -68.91% $485.24 1.88K 03 Nov 2021 Direct F2
transaction CHE capital stock Options Exercise $329K +1.42K +75.27% $231.91 3.3K 04 Nov 2021 Direct
transaction CHE capital stock Options Exercise $968K +4.18K +126.47% $231.91 7.48K 04 Nov 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHE stock option(right to buy with tandem tax withholding) Options Exercise -$329K -1.42K -2.2% $231.91 63.1K 04 Nov 2021 capital stock 1.42K $231.91 Direct F3
transaction CHE stock option(right to buy with tandem tax withholding) Options Exercise -$968K -4.18K -6.61% $231.91 59K 04 Nov 2021 capital stock 4.18K $231.91 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $490.00 to $490.26. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in footnote (1) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $485.00 to $485.75. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3 Vesting in three equal annual installments commencing 11/03/2018